[1]
Haroon, M., Sathiadoss, P., Breau, R.H., Cagiannos, I., Flood, T., Lavallee, L.T., Morash, C. and Schieda, N. 2021. Proportion of clinically significant prostate cancer diagnosed by systematic template biopsy after negative pre-biopsy multiparametric magnetic resonance imaging and predictive value of prostate-specific antigen density. Canadian Urological Association Journal. 16, 3 (Oct. 2021), E178–80. DOI:https://doi.org/10.5489/cuaj.7455.